Vera Therapeutics Stock Price on November 1, 2024
| VERA Stock | USD 46.92 0.59 1.24% |
Below is the normalized historical share price chart for Vera Therapeutics extending back to August 28, 1985. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vera Therapeutics stands at 46.92, as last reported on the 11th of December 2024, with the highest price reaching 48.49 and the lowest price hitting 46.76 during the day.
If you're considering investing in Vera Stock, it is important to understand the factors that can impact its price. Vera Therapeutics appears to be very steady, given 3 months investment horizon. Vera Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.13, which indicates the firm had a 0.13% return per unit of risk over the last 3 months. By inspecting Vera Therapeutics' technical indicators, you can evaluate if the expected return of 0.5% is justified by implied risk. Please review Vera Therapeutics' Semi Deviation of 2.94, risk adjusted performance of 0.0807, and Coefficient Of Variation of 995.08 to confirm if our risk estimates are consistent with your expectations.
At present, Vera Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Capital Stock is expected to grow to about 46.2 K, whereas Common Stock Shares Outstanding is forecasted to decline to about 21.5 M. . At present, Vera Therapeutics' Price Book Value Ratio is projected to increase based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.22, whereas Price To Sales Ratio is forecasted to decline to 282.21. Vera Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of May 2021 | 200 Day MA 40.8871 | 50 Day MA 44.5796 | Beta 1.025 |
Vera |
Sharpe Ratio = 0.1344
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VERA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.75 actual daily | 33 67% of assets are more volatile |
Expected Return
| 0.5 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Vera Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vera Therapeutics by adding it to a well-diversified portfolio.
Price Book 10.4079 | Book Value 5.253 | Enterprise Value 2.7 B | Enterprise Value Ebitda (3.60) | Shares Float 51.5 M |
Related Headline
Cytokinetics Headline on 1st of November 2024
Filed transaction by Cytokinetics Director, Officer: President & Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Vera Therapeutics Valuation on November 1, 2024
It is possible to determine the worth of Vera Therapeutics on a given historical date. On November 1, 2024 Vera was worth 40.46 at the beginning of the trading date compared to the closed value of 43.82. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vera Therapeutics stock. Still, in general, we apply an absolute valuation method to find Vera Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vera Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vera Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 40.43 | 41.55 | 40.27 | 40.38 | 2,458,834 | |
11/01/2024 | 40.46 | 45.27 | 40.45 | 43.82 | 1,403,889 |
| 43.31 | 46.64 | 42.92 | 45.17 | 736,425 |
| Backtest Vera Therapeutics | | | Vera Therapeutics History | | | Vera Therapeutics Valuation | Previous | Next |
Vera Therapeutics Trading Date Momentum on November 1, 2024
| On November 04 2024 Vera Therapeutics was traded for 45.17 at the closing time. The top price for the day was 46.64 and the lowest listed price was 42.92 . The trading volume for the day was 736.4 K. The trading history from November 4, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 3.08% . The trading price change against the current closing price is 11.00% . |
Vera Therapeutics Fundamentals Correlations and Trends
By evaluating Vera Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vera Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vera financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Vera Therapeutics Stock history
Vera Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vera is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vera Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vera Therapeutics stock prices may prove useful in developing a viable investing in Vera Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 42.7 M | 21.5 M | |
| Net Income Applicable To Common Shares | 102.4 M | 107.5 M |
Vera Therapeutics Quarterly Net Working Capital |
|
Vera Therapeutics Stock Technical Analysis
Vera Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Vera Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Vera Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Vera Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Vera Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vera Therapeutics shares will generate the highest return on investment. By undertsting and applying Vera Therapeutics stock market strength indicators, traders can identify Vera Therapeutics entry and exit signals to maximize returns
Vera Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vera Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Vera Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vera to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0807 | |||
| Jensen Alpha | 0.1583 | |||
| Total Risk Alpha | (0.23) | |||
| Sortino Ratio | 0.08 | |||
| Treynor Ratio | 0.2017 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Vera Stock analysis
When running Vera Therapeutics' price analysis, check to measure Vera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vera Therapeutics is operating at the current time. Most of Vera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vera Therapeutics' price. Additionally, you may evaluate how the addition of Vera Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |